Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system (Q44344851)

2 December 2017

title

Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system (English)

1 reference

2 December 2017

F Hernando

1

1 reference

2 December 2017

J A Fuentes

2

1 reference

2 December 2017

M C Fournié-Zaluski

3

1 reference

2 December 2017

B P Roques

4

1 reference

2 December 2017

M Ruiz-Gayo

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

318

1 reference

2 December 2017

issue

2-3

1 reference

2 December 2017

page(s)

221-229

1 reference

Increase in rat cortical [3H]naloxone binding site density after chronic administration of antidepressant agents

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

The role of CCK caerulein, and CCK antagonists in nociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Involvement of endogenous enkephalins in the mouse 'behavioral despair' test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: Correlation with the morphine (μ) receptor binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Enzyme-resistant CCK analogs with high affinities for central receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Cholecystokinin-dopamine interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Evidence of the preferential involvement of .mu.-receptors in analgesia using enkephalins highly selective for peripheral .mu. or .delta. receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Exploring delta-receptor function using the selective opioid antagonist naltrindole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Two brain cholecystokinin receptors: implications for behavioral actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal caps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

In vivo release of CCK-8 from the dorsal horn of the rat: Inhibition by DAGOL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P neuronal systems to stress, in the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Glucocorticoids facilitate the retention of acquired immobility during forced swimming.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

Animal models of depression: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900773-X

10.1016/S0014-2999(96)00773-X

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference